Sort
25,944 grants matching “neurodegeneration”
DEGENERATIVE AND DEMENTING DISEASES OF AGING
$1,991,547University Of California San Francisco · P01 · FY2002 · AG
Traumatic Brain Injury and Repetitive Head Impacts: Contributions to AD/ADRD and CTE Neuropathology and Resulting Clinical Syndromes
$1,989,941Ann Carolyn McKee · Boston University Medical Campus · U54 · FY2022 · NS
The UCLA Udall Parkinson Disease Center of Excellence
$1,989,798Marie-Francoise S Chesselet · University Of California Los Angeles · P50 · FY2010 · NS
CONNECT-TBI
$1,989,272Douglas Hamilton Smith · University Of Pennsylvania · U54 · FY2019 · NS
Potassium Channels and Dendritic Function in Hippocampal Pyramidal Neurons
$1,987,350Dax A Hoffman · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD)
$1,984,624Eti Yoles · Immunobrain Checkpoint Inc. · R01 · FY2021 · AG
Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease
$1,984,309Jessica Alber · University Of Rhode Island · R01 · FY2025 · AG
Cell and molecular pathobiology of Alzheimer's Disease
$1,983,838Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2009 · AG
Vascular contribution to white matter lesions and motor dysfunction in AD and ADRD
$1,983,762Hyung Jin Ahn · Rutgers Biomedical And Health Sciences · RF1 · FY2022 · AG
Epidemiology of Biomarkers of Risk and Progression in LOAD
$1,982,531Richard Mayeux · Columbia University Health Sciences · R01 · FY2011 · AG
Aging, the retromer complex and the neurobiology of Alzheimer's disease
$1,981,250Domenico Pratico · Temple Univ Of The Commonwealth · RF1 · FY2017 · AG
Vps35 dysregulation, a mechanism of AD-like neurodegeneration and dementia in Down syndrome
$1,981,250Domenico Pratico · Temple Univ Of The Commonwealth · RF1 · FY2017 · AG
Small molecule inhibitors of CAPON-induced tau aggregation
$1,980,378Moustafa Gabr · Weill Medical Coll Of Cornell Univ · RF1 · FY2024 · AG
Single-cell transcriptomic and epigenomic analysis of brain cell vulnerabilities to tauopathies in early AD impacted brain regions
$1,979,459Xiangmin Xu · University Of California-Irvine · R01 · FY2025 · AG
Epidemiology of Biomarkers of Risk and Progression in LOAD
$1,978,440Richard Mayeux · Columbia University Health Sciences · R01 · FY2010 · AG
CELL AND MOLECULAR PATHOBIOLGY OF ALZHEIMER'S DISEASE
$1,975,994Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2012 · AG
CELL AND MOLECULAR PATHOBIOLGY OF ALZHEIMER'S DISEASE
$1,975,994Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2014 · AG
Immunometabolic regulation after CNS injury
$1,975,262Krishnan M. Dhandapani · Augusta University · RF1 · FY2023 · NS
Studies in Alzheimer's disease and Neurodegenerative Diseases
$1,975,214Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2018 · AG
Degenerative and Dementing Diseases of Aging
$1,972,358Stanley B Prusiner · University Of California, San Francisco · P01 · FY2015 · AG
Epidemiology of Biomarkers of Risk and Progression in LOAD
$1,971,743Richard Mayeux · Columbia University Health Sciences · R01 · FY2012 · AG
Chemical design of amyloid targeting fluorescent probes
$1,969,999Emmanuel A Theodorakis · University Of California, San Diego · RF1 · FY2018 · AG
Cell Death Regulation by Pro-Apoptotic BOK in Tauopathies
$1,969,620Samuel G Katz · Yale University · RF1 · FY2024 · NS
Nerve growth factor (NGF) metabolic dysfunction as a marker of cognitive decline in autosomal dominant Alzheimer's disease
$1,969,396Yakeel T. Quiroz · Massachusetts General Hospital · RF1 · FY2022 · AG
The UCLA UDALL Parkinson Disease Center of Excellence
$1,967,910Marie-Francoise S Chesselet · University Of California Los Angeles · P50 · FY2007 · NS